Immunoprecise Antibodies Stock Forecast - Value At Risk

IPA Stock  USD 1.25  0.01  0.79%   
Immunoprecise Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Immunoprecise Antibodies stock prices and determine the direction of Immunoprecise Antibodies's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Immunoprecise Antibodies' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Immunoprecise Antibodies' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Immunoprecise Antibodies' systematic risk associated with finding meaningful patterns of Immunoprecise Antibodies fundamentals over time.
Check out Historical Fundamental Analysis of Immunoprecise Antibodies to cross-verify your projections.
For information on how to trade Immunoprecise Stock refer to our How to Trade Immunoprecise Stock guide.
  
As of April 23, 2024, Inventory Turnover is expected to decline to 4.83. In addition to that, Payables Turnover is expected to decline to 2.75. The current year's Common Stock Shares Outstanding is expected to grow to about 30.1 M, whereas Net Loss is projected to grow to (22.7 M).

Open Interest Against 2024-05-17 Immunoprecise Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Immunoprecise Antibodies' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Immunoprecise Antibodies' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Immunoprecise Antibodies stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Immunoprecise Antibodies' open interest, investors have to compare it to Immunoprecise Antibodies' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Immunoprecise Antibodies is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Immunoprecise. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Immunoprecise Antibodies has current Value At Risk of 0.
Most investors in Immunoprecise Antibodies cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Immunoprecise Antibodies' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Immunoprecise Antibodies' price structures and extracts relationships that further increase the generated results' accuracy.
Check Immunoprecise Antibodies VolatilityBacktest Immunoprecise AntibodiesInformation Ratio  

Immunoprecise Antibodies Trading Date Momentum

On April 23 2024 Immunoprecise Antibodies was traded for  1.25  at the closing time. Highest Immunoprecise Antibodies's price during the trading hours was 1.26  and the lowest price during the day was  1.23 . There was no trading activity during the period 0.0. Lack of trading volume on the 23rd of April did not cause price change. The trading delta at closing time to current price is 0.80% .
Compare Immunoprecise Antibodies to competition

Other Forecasting Options for Immunoprecise Antibodies

For every potential investor in Immunoprecise, whether a beginner or expert, Immunoprecise Antibodies' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Immunoprecise Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Immunoprecise. Basic forecasting techniques help filter out the noise by identifying Immunoprecise Antibodies' price trends.

View Immunoprecise Antibodies Related Equities

 Risk & Return  Correlation

Immunoprecise Antibodies Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Immunoprecise Antibodies' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Immunoprecise Antibodies' current price.

Immunoprecise Antibodies Market Strength Events

Market strength indicators help investors to evaluate how Immunoprecise Antibodies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Immunoprecise Antibodies shares will generate the highest return on investment. By undertsting and applying Immunoprecise Antibodies stock market strength indicators, traders can identify Immunoprecise Antibodies entry and exit signals to maximize returns.

Immunoprecise Antibodies Risk Indicators

The analysis of Immunoprecise Antibodies' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Immunoprecise Antibodies' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting immunoprecise stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Immunoprecise Antibodies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Immunoprecise Antibodies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Immunoprecise Antibodies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Immunoprecise Antibodies Stock:
Check out Historical Fundamental Analysis of Immunoprecise Antibodies to cross-verify your projections.
For information on how to trade Immunoprecise Stock refer to our How to Trade Immunoprecise Stock guide.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Complementary Tools for Immunoprecise Stock analysis

When running Immunoprecise Antibodies' price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.47)
Revenue Per Share
0.939
Quarterly Revenue Growth
0.203
Return On Assets
(0.11)
Return On Equity
(0.26)
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunoprecise Antibodies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.